SVB co-leads $125 mln debt financing of HLS Therapeutics
Silicon Valley Bank (SVB) has co-led a $100 million senior secured term loan and $25 million senior secured revolver for HLS Therapeutics Inc (TSX-V: HLS), a Toronto-based pharmaceutical company specializing in the central nervous system and cardiovascular markets. The deal will refinance the company's existing debt and provide working capital. Founded in 2015 and led by CEO Greg Gubitz, HLS is focused on acquiring and commercializing late-stage development branded pharmaceutical products in North America. SVB, a U.S. technology financial services firm, established its first branch in Canada earlier this year.
12 September 2018•2 mins read
